Study to Learn More About the Effect of a New Drug Called BAY2327949 on the Blood Flow Through Kidneys in Adult Participants With Moderate Chronic Kidney Disease

NCT04552262 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

7

Enrollment

INDUSTRY

Sponsor class

Stopped Terminated

Conditions

Moderate Chronic Kidney Disease

Interventions

DRUG: BAY2327949
DRUG: Placebo

Sponsor

Bayer